News About: Pharm. Industry
Dong Wha starts to develop first generic of Champix, antismoking treatmentDong Wha Pharm has started to develop generics of Champix, an antismoking treatment. Among the domestic companies which filed patent lawsuits of Champix against Pfizer, the orig...
|
Listed pharmaceutical companies’ sales management expenses about to go under 30%
This year, the average sales management expense ratios to sales decreased to less than 30% among listed pharmaceutical in the KOSPI and the same ratio of KOSDAQ listed pharmaceutical companies has still remained above...
‘Detailed’ regulations to support academic conferences by KPMA
After informing the pharmaceutical association of the supporting scale and details of an international symposium held by an academic society in Korea, a pharmaceutical company supported expenses of the symposium direc...
Listed pharmaceutical companies spend over KRW 300 billion into advertisement
It was observed listed pharmaceutical companies’ advertisement expenses up to the last September exceeded KRW 300 billion.
Moreover, Kwang Dong Pharmaceutical spend the most money, KRW 30 billion, in advertisement, a...
Pharmaceutical companies in KOSPI outnumbered ones in KOSPI in 3rd quarter
It was observed the average sales growth rate of KOSPI listed pharmaceutical companies, 6.1%, was higher than the one of KOSDAQ listed pharmaceutical companies by over 4%, and the average year-on-year sales growth rat...
Co-promotion of Yuhan with multinational companies contributes to API export expansionYuhan Corporation has recently made extraordinary moves. After the appointment of CEO Jung-hee Lee, the company has put investments worth of approximately KRW 45 billion in Bion...
|
Listed pharmaceutical companies own cashable assets of KRW 1.5694 trillion
Listed pharmaceutical companies have continuously increased the holding amount of cashable assets.
According to the Yakup Shinmoon’s analysis result of 3rd quarter’s reports of KOSPI and KOSDAQ listed pharmaceutical ...
Pharmaceutical association’s active discussion about Wage Peak System
In the employment and labor market where the youth unemployment and extension of retirement age have become controversy, while the adoption of the Wage Peak System is expected to be widely discussed, the domestic phar...
Hanmi Pharm announces a Chinese sales license agreement of new lung cancer treatment with ZAI LabOn the 23rd, Hanmi Pharm(CEO Kwan-soon Lee) announced an exclusive license agreement to handle the self-developed targeted lung cancer treatment(HM61713) across China(including ...
|
“There is no legal flaw on recommending faulty employees to resign”
[Case 1] Is a company lawful to fire a person who attacked and made a section chief unconscious while drunk and making a phone call inside of the company building?
Around the time when the person is about to be fired...
